Medtech.Moscow and "Created by Moscow doctors" - the assembly point of biomedical technologies

At the Medtech stand.Moscow, which will launch its work as part of the Startup Village technofestival 2026, visitors will be presented:

• new generation Russian sequencers — compact R-Gene 100 and high-performance R-Gene 2000 for genomic research,
• metabolic passport - analysis of 250+ metabolites and lipids as a basis for personal prevention,
• test system for predicting the response to immunotherapy in cancer patients — accuracy above 92%,
• a platform from Marlin Biotech for the gene therapy of hereditary diseases — a drug for Duchenne myodystrophy is already in phase II clinical trials,
• NGS-523-gene panel for the selection of personalized therapy for cancer patients — the first validated in Russia,
• plus mRNA immunoadjuvants for cancer therapy, analysis of tumor DNA circulating in the blood, test systems for autoimmune diseases.